124 related articles for article (PubMed ID: 14724570)
21. Bioluminescent molecular imaging of endogenous and exogenous p53-mediated transcription in vitro and in vivo using an HCT116 human colon carcinoma xenograft model.
Wang W; El-Deiry WS
Cancer Biol Ther; 2003; 2(2):196-202. PubMed ID: 12750563
[TBL] [Abstract][Full Text] [Related]
22. V-myc in a simple, single gene retroviral vector causes rapid induction of leukemia and concomitant apoptosis following bone marrow transplantation.
Dolnikov A; Shounan Y; Millington M; Mackenzie K; Symonds G
Leukemia; 1998 Apr; 12(4):542-53. PubMed ID: 9557613
[TBL] [Abstract][Full Text] [Related]
23. Protection of retrovirus-induced disease by transplantation of bone marrow cells transduced with MuLV env gene via retrovirus vector.
Kitagawa M; Aizawa S; Kamisaku H; Hirokawa K; Ikeda H
Exp Hematol; 1999 Feb; 27(2):234-41. PubMed ID: 10029162
[TBL] [Abstract][Full Text] [Related]
24. Targeting p53 in cancer.
Chène P
Curr Med Chem Anticancer Agents; 2001 Aug; 1(2):151-61. PubMed ID: 12678764
[TBL] [Abstract][Full Text] [Related]
25. p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome.
Nakase M; Inui M; Okumura K; Kamei T; Nakamura S; Tagawa T
Mol Cancer Ther; 2005 Apr; 4(4):625-31. PubMed ID: 15827336
[TBL] [Abstract][Full Text] [Related]
26. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model.
Ko SC; Gotoh A; Thalmann GN; Zhau HE; Johnston DA; Zhang WW; Kao C; Chung LW
Hum Gene Ther; 1996 Sep; 7(14):1683-91. PubMed ID: 8886839
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia model.
Gravatt LC; Chaffee S; Hebert ME; Halperin EC; Friedman HS; Kurtzberg J
Leukemia; 1993 Aug; 7(8):1261-7. PubMed ID: 8350627
[TBL] [Abstract][Full Text] [Related]
28. Participation of p53 protein in the cellular response to DNA damage.
Kastan MB; Onyekwere O; Sidransky D; Vogelstein B; Craig RW
Cancer Res; 1991 Dec; 51(23 Pt 1):6304-11. PubMed ID: 1933891
[TBL] [Abstract][Full Text] [Related]
29. p53 (TRP53) deficiency-mediated antiapoptosis escape after 5 Gy X irradiation still induces stem cell leukemia in C3H/He mice: comparison between whole-body assay and bone marrow transplantation (BMT) assay.
Yoshida K; Hirabayashi Y; Wada S; Watanabe F; Watanabe K; Aizawa S; Inoue T
Radiat Res; 2007 Jun; 167(6):703-10. PubMed ID: 17523849
[TBL] [Abstract][Full Text] [Related]
30. DNA-dependent protein kinase enhances DNA damage-induced apoptosis in association with Friend gp70.
Yamaguchi S; Hasegawa M; Aizawa S; Tanaka K; Yoshida K; Noda Y; Tatsumi K; Hirokawa K; Kitagawa M
Leuk Res; 2005 Mar; 29(3):307-16. PubMed ID: 15661267
[TBL] [Abstract][Full Text] [Related]
31. Suppression of acute lymphoblastic leukemia by the human wild-type p53 gene.
Cheng J; Yee JK; Yeargin J; Friedmann T; Haas M
Cancer Res; 1992 Jan; 52(1):222-6. PubMed ID: 1727382
[TBL] [Abstract][Full Text] [Related]
32. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53.
Kichina JV; Rauth S; Das Gupta TK; Gudkov AV
Oncogene; 2003 Jul; 22(31):4911-7. PubMed ID: 12894234
[TBL] [Abstract][Full Text] [Related]
33. Is conversion of solid into more anoxic ascites tumors associated with p53 inactivation?
Magnusson KP; Satalino R; Qian W; Klein G; Wiman KG
Oncogene; 1998 Nov; 17(18):2333-7. PubMed ID: 9811464
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
Shono T; Tofilon PJ; Schaefer TS; Parikh D; Liu TJ; Lang FF
Cancer Res; 2002 Feb; 62(4):1069-76. PubMed ID: 11861384
[TBL] [Abstract][Full Text] [Related]
36. [Advances of studies on members of P53 family, interaction and relation with leukemia -review].
Xie MX; Xie YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1331-5. PubMed ID: 24156460
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.
Kitagawa M; Kamisaku H; Aizawa S; Sado T
Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008
[TBL] [Abstract][Full Text] [Related]
38. Role of the p53 tumor suppressor gene in the pathogenesis and in the suppression of acute lymphoblastic T-cell leukemia.
Yeargin J; Cheng J; Haas M
Leukemia; 1992; 6 Suppl 3():85S-91S. PubMed ID: 1602834
[TBL] [Abstract][Full Text] [Related]
39. Alteration of classical and hematopoiesis specific p53 pathway in the bone marrow hematopoietic stem/progenitor compartment facilitates leukemia progression in experimental mice.
Chatterjee R; Chattopadhyay S; Law S
Leuk Res; 2016 Aug; 47():70-7. PubMed ID: 27280487
[TBL] [Abstract][Full Text] [Related]
40. Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53.
Odin L; Favrot M; Poujol D; Michot JP; Moingeon P; Tartaglia J; Puisieux I
Cancer Gene Ther; 2001 Feb; 8(2):87-98. PubMed ID: 11263530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
